Mitochondrial metabolism and macrophage function post MI
Mitochondrial metabolism and macrophage function post MI
批准号:
10630833
负责人:
Rong Tian
金额:
$69.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-01 至 2025-06-30
关键词:
AffectAnabolismAnti-Inflammatory AgentsBehaviorBiological AssayBone MarrowCarbonCardiacCardiac healthCellsChIP-seqComplexCuesEnergy MetabolismEpigenetic ProcessGenerationsGlycolysisHeartHeart DiseasesImmunologyImpairmentInfarctionInfiltrationInflammatoryInflammatory ResponseInterleukin-13Interleukin-4LeadLeukocytosisLigandsLinkLipopolysaccharidesMacrophageMacrophage ActivationMeasuresMediatingMetabolicMetabolic PathwayMetabolismMitochondriaMolecularMusMyelogenousMyeloid CellsMyocardial InfarctionNADHNADPNatural ImmunityOutcomeOxidation-ReductionOxidative PhosphorylationOxygen ConsumptionPatternPentosephosphate PathwayPhagocytosisPhasePhenotypePlayProductionProliferatingProteinsRNA SequencesResearchRespirationRoleSignal TransductionSiteSystemTestingTimeToll-like receptorsTranscriptional Regulationcytokineheart functionhistone methylationhistone modificationinterestischemic injurymetabolomicsmitochondrial metabolismmortalitypost interventionrecruittherapeutic targettissue repairtranscriptometreatment effectwound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Macrophages are key components of innate immunity system. It emerged recently that macrophages play critical
roles in heart health and diseases. Following myocardial infarction (MI), macrophage is recruited in high number
to the infarct site and acts as a key regulator in post-MI remodeling, generating proinflammatory signals early
and reparative cues later. However, it is not well understood how macrophage function is regulated during the
period of rapid change. Of interest, transcriptome analysis of macrophage in the infarct zone showed a time-
dependent reprogramming of mitochondrial function during the first week post-MI when macrophage phenotype
transitions from proinflammatory to reparative. This raises the question whether mitochondrial metabolism in
macrophage is causally linked to the outcome of post-MI remodeling, and if so, what the underlying mechanisms
are. Immunology research finds that macrophage activation is accompanied by global rewiring of the metabolic
pathway. Proinflammatory macrophage, elicited by Toll-like receptor ligands lipopolysaccharide (LPS), shifts it
energy metabolism from oxidative phosphorylation towards glycolysis. Such a metabolic switch is thought to
favor rapid energy production and increased demand for biosynthesis, and fuel pentose phosphate pathway for
NADPH generation, all lead to high levels of ROS and proinflammatory cytokines. On the other hand, the Th2
cytokines IL-4 and IL-13 induce alternative activation which promotes anti-inflammatory activity, wound healing
and tissue repair, and presents the opposite metabolic pattern. Although the metabolic switch has been well
described, questions remain whether differential metabolic activity (i.e., use of glycolysis versus mitochondrial
respiration) is a coincidence, a consequence of changes in phenotype, or a direct driver of macrophage function.
It is also unclear whether similar mechanisms apply to cardiac macrophages. To decipher the mechanistic role
of mitochondrial function in macrophage phenotype, we analyzed the phenotype of macrophage with impaired
mitochondrial respiration due to deletion of Ndufs4, a mitochondrial Complex I protein (KO). KO increased
glycolysis and reduced oxygen consumption in bone marrow derived macrophage (BMDM), and demonstrated
exacerbated inflammatory response to LPS stimulation. In mice with myeloid-specific deletion of Ndufs4 (mKO)
we showed increased mortality and poor cardiac function after MI. These observations led us to hypothesize that
mitochondrial function is a key regulator of macrophage polarization during post-MI remodeling and
hence a potential therapeutic target. To test the hypothesis, we will investigate the mechanistic link between
mitochondrial function and epigenetic reprogramming during stimulation in primary macrophages, and
furthermore, test the effects of manipulating mitochondrial function in macrophage function and post-MI
remodeling in mice.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s11886-023-01897-4
发表时间:
2023-07
期刊:
CURRENT CARDIOLOGY REPORTS
影响因子:
3.7
作者:
[Banerjee, Durba, Tian, Rong, Cai, Shanshan]
通讯作者:
Cai, Shanshan
DOI:
10.1172/jci139828
发表时间:
2022-03-01
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
[Wu J, Singh K, Lin A, Meadows AM, Wu K, Shing V, Bley M, Hassanzadeh S, Huffstutler RD, Schmidt MS, Blanco LP, Tian R, Brenner C, Pirooznia M, Kaplan MJ, Sack MN]
通讯作者:
Sack MN
DOI:
10.1038/s41569-021-00610-8
发表时间:
2021-10
期刊:
Nature reviews. Cardiology
影响因子:
--
作者:
[]
通讯作者:
Mitochondrial metabolism and macrophage function post MI
-
批准号:10421059
-
项目类别:
-
资助金额:$74.08万
-
财政年份:2020
-
负责人:Rong Tian
-
依托单位:
Mitochondrial function and glycolytic switch in pathological cardiac hypertrophy
-
批准号:9925814
-
项目类别:
-
资助金额:$58.64万
-
财政年份:2018
-
负责人:Rong Tian
-
依托单位:
Fatty acid oxidation suppresses cardiac hypertrophy
-
批准号:9100917
-
项目类别:
-
资助金额:$68.97万
-
财政年份:2015
-
负责人:Rong Tian
-
依托单位:
Fatty acid oxidation suppresses cardiac hypertrophy
-
批准号:8977407
-
项目类别:
-
资助金额:$68.64万
-
财政年份:2015
-
负责人:Rong Tian
-
依托单位:
Glucose And BCAA Metabolism in the Heart
-
批准号:9035425
-
项目类别:
-
资助金额:$77.48万
-
财政年份:2014
-
负责人:Rong Tian
-
依托单位:
Glucose And BCAA Metabolism in the Heart
-
批准号:8711853
-
项目类别:
-
资助金额:$77.48万
-
财政年份:2014
-
负责人:Rong Tian
-
依托单位:
Glucose And BCAA Metabolism in the Heart
-
批准号:8822324
-
项目类别:
-
资助金额:$76.31万
-
财政年份:2014
-
负责人:Rong Tian
-
依托单位:
Glucose And BCAA Metabolism in the Heart
-
批准号:9256515
-
项目类别:
-
资助金额:$77.48万
-
财政年份:2014
-
负责人:Rong Tian
-
依托单位:
Complex I Deficiency Triggered Acceleration of Heart Failure
-
批准号:8676927
-
项目类别:
-
资助金额:$61.37万
-
财政年份:2011
-
负责人:Rong Tian
-
依托单位:
Complex I Deficiency Triggered Acceleration of Heart Failure
-
批准号:8318138
-
项目类别:
-
资助金额:$62.86万
-
财政年份:2011
-
负责人:Rong Tian
-
依托单位:
Complex I Deficiency Triggered Acceleration of Heart Failure
-
批准号:8486485
-
项目类别:
-
资助金额:$60.69万
-
财政年份:2011
-
负责人:Rong Tian
-
依托单位:
Complex I Deficiency Triggered Acceleration of Heart Failure
-
批准号:8195391
-
项目类别:
-
资助金额:$76.71万
-
财政年份:2011
-
负责人:Rong Tian
-
依托单位:
Glycogen metabolism and PRKAG2 cardiomyopathy
-
批准号:7251255
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2007
-
负责人:Rong Tian
-
依托单位:
Glycogen metabolism and PRKAG2 cardiomyopathy
-
批准号:7422333
-
项目类别:
-
资助金额:$41.23万
-
财政年份:2007
-
负责人:Rong Tian
-
依托单位:
Isoform-specific function of y-AMPK in the heart.
-
批准号:8249682
-
项目类别:
-
资助金额:$50.82万
-
财政年份:2007
-
负责人:Rong Tian
-
依托单位:
Glycogen metabolism and PRKAG2 cardiomyopathy
-
批准号:7619484
-
项目类别:
-
资助金额:$41.23万
-
财政年份:2007
-
负责人:Rong Tian
-
依托单位:
Isoform-specific function of y-AMPK in the heart.
-
批准号:8585869
-
项目类别:
-
资助金额:$51.79万
-
财政年份:2007
-
负责人:Rong Tian
-
依托单位:
Isoform-specific function of y-AMPK in the heart.
-
批准号:8764728
-
项目类别:
-
资助金额:$52.09万
-
财政年份:2007
-
负责人:Rong Tian
-
依托单位:
Glycogen metabolism and PRKAG2 cardiomyopathy
-
批准号:7878777
-
项目类别:
-
资助金额:$41.01万
-
财政年份:2007
-
负责人:Rong Tian
-
依托单位:
Isoform-specific function of y-AMPK in the heart.
-
批准号:8389882
-
项目类别:
-
资助金额:$50.12万
-
财政年份:2007
-
负责人:Rong Tian
-
依托单位:
海外基金